Navigation Links
Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839

LOUISVILLE, Colo., June 26, 2007 /PRNewswire-FirstCall/ -- Replidyne, Inc. today announced results from three Phase I trials studying REP8839, a novel topical antibiotic that has shown potent in vitro activity against major skin pathogens including methicillin-resistant S. aureus (MRSA). The results of the Phase I trials show that topically applied REP8839 appears safe, well-tolerated and associated with low systemic exposure, or drug absorption into the bloodstream, which is desirable for a topical antibiotic treatment. Based on these results, Replidyne plans to initiate Phase II trials in children with impetigo, the most common bacterial skin infection, by the end of the year.

"REP8839 is a promising development candidate and has the potential to be an important treatment option for physicians in the ongoing fight against drug-resistant infections including MRSA, a growing public health concern," said Kenneth J. Collins, Replidyne's President and Chief Executive Officer. "With these safety data, we intend to move forward into Phase II trials to study the safety and efficacy of REP8839 in patients with impetigo and other skin and wound infections."

REP8839 was tested in three Phase I trials which collectively enrolled over 400 subjects. In the first Phase I trial, safety, tolerability and skin irritancy were tested following repeated daily application of REP8839, at three drug concentrations (1%, 2% and 4%), on intact and abraded skin. Irritancy scores comparable to placebo were recorded for all REP8839 exposed test subjects. In the second study, in addition to safety, tolerability and dermal irritancy, systemic exposure was examined following repeated daily application of REP8839 on a larger surface area of intact and abraded skin. In all subjects, REP8839 was associated with low systemic exposure and low skin irritancy. In the third study, a 2% formulation of REP8839 was tested for its ability
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Replidyne Phase II Pediatric Trial Meets Primary Objective
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:5/27/2015)... 27, 2015   Madison Laser Tattoo Removal is ... Madison and the surrounding area to offer treatments ... Laser Tattoo Removal is dedicated to bringing a solution to ... . "I founded Madison Laser Tattoo Removal ... return their skin to its natural look," said Emily ...
(Date:5/27/2015)... OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts ... a series of diverse complications arising from the presence ... tissues, which cause a rapidly progressing hyperactive host immune ... 50% depending on disease severity. The syndrome places a ... global marketplace, which for the purposes of this report ...
(Date:5/27/2015)... 27, 2015 Protein purification involves the process ... in their physical properties. The objective of a protein ... functional protein with fewest contaminants. The global protein purification ... CAGR of around 5% to 6% during the forecast ... in the pharmaceutical and biotechnological fields, growing need to ...
Breaking Medicine Technology:Madison Laser Tattoo Removal Brings Superior Laser Tattoo Removal Services To Madison, WI With Astanza Duality 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 3OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 4Protein Purification & Isolation Market by Technology by Product by Application & End User - Global Forecast to 2020 2Protein Purification & Isolation Market by Technology by Product by Application & End User - Global Forecast to 2020 3
(Date:5/27/2015)... May 27, 2015 The BBB Code ... service practices that enhance customer trust and confidence in ... for Trust, eight principles that summarize important elements of ... represents standards for business accreditation by BBB. Businesses based ... standards and complete application procedures will be accredited by ...
(Date:5/27/2015)... Phoenix, Arizona (PRWEB) May 27, 2015 ... a mission of healthier patients in the community, ... Research Center (formerly John C. Lincoln). SmartPractice Vice President ... Sales Michelle Shaw presented a $25,000 check to Paulla ... at HonorHealth’s Breast Health & Research Center on April ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Allred Dental located ... help patients - who need extensive dental treatment - understand ... treatment options customized for their problems. , Dr. Jeff Allred ... visual presentation of the assessment of the patient’s oral health ... which can treat their oral health problems. , “The dental ...
(Date:5/27/2015)... Black Book Rankings, well known ... the multiple services and software industries, conducted a ... ranked Electronic Health and Medical Record software systems ... focus on implemented EHR users, Black Book reveals ... the highest scores in client experience among small ...
(Date:5/27/2015)... The MedSpa at Hendrick is excited ... treatments in Abilene, Texas: Xeomin®, Belotero Balance® and Radiesse®. ... glabellar lines, better known as the lines between the ... to treat smoker’s lines around the mouth and marionette ... improves the appearance of smile lines or lines around ...
Breaking Medicine News(10 mins):Health News:Carson Energy Receives A+ Accredited Rating For 19 Consecutive Years 2Health News:SmartPractice Donates $25,000 to HonorHealth Breast Health and Research Center 2Health News:San Marcos Dentistry Office Offering a New Service Dental Case Planning 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2
... By Madonna Behen HealthDay Reporter , THURSDAY, Jan. ... brain changes once you become an expert at something, Japanese ... rewired the brains of professional shogi players. Neuroscientists at ... group of professional and amateur shogi players. Shogi is the ...
... Ultrasound in Medicine (AIUM) announced today that ultrasound practice ... sets the standard for care in fetal echocardiography and ... fostering its safe and effective use. "I am ... providers to show that they meet or exceed training ...
... HealthDay Reporter , THURSDAY, Jan. 20 (HealthDay News) -- ... marks for advances in treating people with tobacco-related illnesses, but ... anti-smoking programs falter. The report, from the American Lung ... people to stop smoking or help them quit. "We ...
... , This release is available in Spanish ... of Granada warns about the negative effects of the ... and attitudes of men towards women, which are based on ... themselves for women. The research revealed that when individuals ...
... pulmonary disease (COPD) who are on long-term oxygen therapy ... According to a new study by researchers in Sweden, ... of death from cardiovascular disease and other non-respiratory ailments. ... for these conditions and treat them to help decrease ...
... Wash. Washington State University sleep researchers have determined that ... Lexington, Ky., commuter flight was substantially fatigued when he ... the wrong runway and cleared it for takeoff. , ... , the researchers come short of saying his fatigue ...
Cached Medicine News:Health News:Experts' Brains Work Differently Than Amateurs' 2Health News:Experts' Brains Work Differently Than Amateurs' 3Health News:AIUM announces ultrasound practice accreditation in fetal echocardiography 2Health News:40 States Get an 'F' in Tobacco Prevention From New Report Card 2Health News:40 States Get an 'F' in Tobacco Prevention From New Report Card 3Health News:Warning about 'benevolent sexism' and men's apparently positive attitudes towards women 2Health News:Causes of death shifting in patients diagnosed with COPD 2Health News:WSU researchers apply fatigue model to fatal commuter air crash 2
... Aestiva Excellence for the Induction Room., ... for the Induction Room. The Aestiva/5 Induction ... anesthesia systems, which helps make it easier ... enhanced features include pneumatic gas mixing, O2 ...
... excellence and economy., ,The Aestiva/5 Compact ... basic ventilation at a moderate price. While ... Aestiva/5 Anesthesia System - open architecture, integrated ... a configurable version of Datex-Ohmeda's newest ventilation ...
... patient care., ,S/5 Anesthesia Delivery Unit ... delivery. As part of the S/5 Anesthesia ... controlled gas delivery and agent vaporization with ... a truly integrated system. The S/5 ADUs ...
A non-adhering hydrogel sheet dressing for use on all partial and full thickness wounds (excluding 3rd degree burns.) Hydrogel sheet contains 96% water and 4% insoluble cross-linked polyethylene oxid...
Medicine Products: